Development of a Novel Convolution Neural Network for Arrhythmia Classification



Status:Not yet recruiting
Conditions:Cardiology, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:9/9/2018
Start Date:October 2018
End Date:October 2019
Contact:Sanjeev Bhavnani, MD
Email:bhavnani.sanjeev@scrippshealth.org
Phone:6308028202

Use our guide to learn which trials are right for you!

Development of a Novel Convolution Neural Network for Arrhythmia Classification: The REVIVE-ECG Validation Trial

Identifying the correct arrhythmia at the time of a clinic event including cardiac arrest is
of high priority to patients, healthcare organizations, and to public health. Recent
developments in artificial intelligence and machine learning are providing new opportunities
to rapidly and accurately diagnose cardiac arrhythmias and for how new mobile health and
cardiac telemetry devices are used in patient care. The current investigation aims to
validate a new artificial intelligence statistical approach called 'convolution neural
network classifier' and its performance to different arrhythmias diagnosed on 12-lead ECGs
and single-lead Holter/event monitoring. These arrhythmias include; atrial fibrillation,
supraventricular tachycardia, AV-block, asystole, ventricular tachycardia and ventricular
fibrillation, and will be benchmarked to the American Heart Association performance criteria
(95% one-sided confidence interval of 67-92% based on arrhythmia type). In order to do so,
the study approach is to create a large ECG database of de-identified raw ECG data, and to
train the neural network on the ECG data in order to improve the diagnostic accuracy.


Inclusion Criteria:

- All ECG data compiled from 12-lead ECG, single, and multiple lead databases

Exclusion Criteria:
We found this trial at
1
site
San Diego, California 92037
?
mi
from
San Diego, CA
Click here to add this to my saved trials